2026 NPPES data Pediatric Neurodevelopmental Disabilities Physician NPI 1255441994 MD
Verify on CMS →

Karen Carter, MD

Pediatric Neurodevelopmental Disabilities Physician in Augusta, Georgia.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 286 in Pediatric Neurodevelopmental Disabilities Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
13K
Medicare Part D claims · 268 beneficiaries · Pediatric Neurodevelopmental Disabilities Physician avg: 512
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.8K
94 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Karen Carter, MD filed 13,100 Medicare Part D claims in 2024 as a Pediatric Neurodevelopmental Disabilities Physician in Augusta, Georgia, prescribing 94% generic.

13K
Part D claims, 2024
94%
generic prescribing
$1.8K
industry payments (Sunshine Act)
≥98th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Karen Carter, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1255441994), first enumerated 08/30/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 13,100 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $1.8K in reported industry payments (94 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

Compare Carter with other Pediatric Neurodevelopmental Disabilities Physician providers

Same primary specialty, same federal CMS NPPES roster.

Also enrolled in Georgia

Other specialties in Augusta: Behavior Technician (456) · Student in an Organized Health Care Education/Training Program (436) · Internal Medicine Physician (364) · Family Nurse Practitioner (243)

Pediatric Neurodevelopmental Disabilities Physician state by state →

CMS NPPES provider registry desk

NPI 1255441994 · Pediatric Neurodevelopmental Disabilities Physician

NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-HEAVY · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1255441994
  • ENUM-LEGACY 2006
  • TAX-TRACE 286
  • RX-HEAVY 13K claims
  • BOOK-THIN 5 in Georgia
  • PHOTO-ENUM Imad Jarjour, M.D. · 2006

Karen Carter, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

13,100 ≥ 98th percentile 98% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). Below this entry. 1,400–1,600: 23,183 prescribers (2%). Below this entry. 1,600–1,800: 19,917 prescribers (1%). Below this entry. 1,800–2,000: 17,585 prescribers (1%). Below this entry. 2K+: 226,899 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

◑
Board-eligible specialty (heuristic, not verified)

Karen Carter, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Karen Carter, MD?

Quality data not reported

NPI registry status

Active

Issued 08/30/2006

NPI 1255441994

Primary specialty

Pediatric Neurodevelopmental Disabilities Physician

Rare

286 US NPIs in this specialty

Medicare Part D claims

13,100 26× vs specialty avg

2024 prescription claims

Specialty avg: 512

Specialty distribution in Georgia

How Pediatric Neurodevelopmental Disabilities Physician compares to other specialties among Georgia providers

Georgia providers
Behavior Technician7.5%Student in an Organized Heal…5%Pharmacist5%Family Nurse Practitioner4.8%Physical Therapist3.9%Professional Counselor3.6%Pediatric Neurodevelopmental…0%
Largest specialties in Georgia (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Neurodevelopmental Disabilities Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1303 D'ANTIGNAC STREET
Augusta, GA 30901

Provider Details

NPI 1255441994
Specialty Pediatric Neurodevelopmental Disabilities Physician
Credentials MD
Gender Female
NPI Issued 08/30/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Karen Carter, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.8K

Largest payer

Supernus Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Karen Carter, MD - brand share 6.0%
Pediatric Neurodevelopmental Disabilities Physician average

6% brand-name claims vs 94% generic, on 13,100 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

13,100
Total Claims
$1.1M
Total Drug Cost
268
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
14,568.8
Total Day Supply
412,643
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$806K
Generic Drug Cost
$338K
Opioid Claims
50 (0.4% rate)
Antibiotic Claims
143

Patient Demographics

Average Patient Age
39.5 years
Avg HCC Risk Score
0.92
Gender Split
37% female / 63% male
Age Distribution
<65: 241, 65-74: 21, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Karen Carter, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Trazodone Hcl
1,004
Risperidone
581
Clonidine Hcl
427
Quetiapine Fumarate
342
Divalproex Sodium
304
Doxepin Hcl
263
Simvastatin
248
Omeprazole
236
Fluticasone Propionate
229
Levothyroxine Sodium
224

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Neurodevelopmental Disabilities Physician Overview

How Karen Carter, MD fits within the Pediatric Neurodevelopmental Disabilities Physician landscape nationally.

286
Pediatric Neurodevelopmental Disabilities Physician Providers in US
41
States with Pediatric Neurodevelopmental Disabilities Physician
512
Avg Claims per Provider

Karen Carter, MD's 13,100 claims are above the specialty average of 512.

Nationwide Pediatric Neurodevelopmental Disabilities Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Carter, both outside Georgia so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Frequently Asked Questions

What is Karen Carter, MD's specialty? ▼
Karen Carter, MD specializes in Pediatric Neurodevelopmental Disabilities Physician and practices in Augusta, Georgia. Credentials: MD.
How much does Karen Carter, MD prescribe under Medicare Part D? ▼
In 2024, Karen Carter, MD wrote 13,100 Medicare Part D claims totaling $1.1M in drug costs for 268 beneficiaries.
Where is Karen Carter, MD located? ▼
Karen Carter, MD is located at 1303 D'ANTIGNAC STREET, Augusta, GA, 30901. Phone: (706) 396-0600.
What is Karen Carter, MD's NPI number? ▼
Karen Carter, MD's National Provider Identifier (NPI) is 1255441994, issued on 08/30/2006.
Does Karen Carter, MD prescribe more brand-name or generic drugs? ▼
Karen Carter, MD's prescribing is 6% brand-name and 94% generic drugs by claim count, with $806K in brand drug costs.
Does Karen Carter, MD prescribe opioids? ▼
Yes, Karen Carter, MD had 50 opioid claims in 2024 with an opioid prescribing rate of 0.4%.
How many Pediatric Neurodevelopmental Disabilities Physician providers are there in the US? ▼
There are 286 Pediatric Neurodevelopmental Disabilities Physician providers across 41 states in the US. The average Pediatric Neurodevelopmental Disabilities Physician provider writes 512 Medicare Part D claims per year.
What drugs does Karen Carter, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Karen Carter, MD's most frequently prescribed drugs include Trazodone Hcl, Risperidone, Clonidine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Karen Carter, MD accept Medicare? ▼
Karen Carter, MD appears in CMS Medicare data with 13,100 Part D claims and 268 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Karen Carter, MD's credentials? ▼
Karen Carter, MD's NPI is 1255441994 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.